Upcoming results from clinical trials for treating relapsed, low grade lymphoma
Overview of the SIRIUS clinical trial in the treatment of multiple myeloma
COMy 2017: Day 2 discussion on relapsed myeloma, treatment, plasma cell leukemia and awards
Arnon Nagler et al.
Changing epigenetic markers in CLL patients on ibrutinib
What are the challenges of allogeneic stem cell transplant in myeloma?